So, repotrectinib is a kind of medicine that’s meant to help with ROS1-positive NSCLC and NTRK-fusion cancers. It works by aiming at lots of those kinase things that help these cancers grow.
Repotrectinib is administrated as 40 mg capsules and comes with the dosage recommendation as 160 mg taken once daily for a duration of 14 days, followed by 160 mg taken twice daily. Each bottle’s got 60 capsules, which should cover the whole treatment for one person.
